Risorse esterne
Opinione della community
Prezzo Variazione Volume
4.7 +2.62 €
P/E Obiettivo ad 1anno
0 10.5 €

Compra - Vendi

Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Altri utenti che hanno investito

Transations in last week
Buy: 7
Sell : 1

Re di cuori



Stock Review & Consensus Look at Akari Therapeutics, Plc (:AKTX), OMNOVA Solutions Inc. (NYSE:OMN) - Midway Monitor

Stock research firms currently have a positive stance on shares of Akari Therapeutics, Plc (:AKTX). Analysts are projecting that the stock will reach $10.50 on a short term (1 year) basis. The majority of analysts covering the equity have either a Buy ...altro » Leggi

Akari Therapeutics PLC (AKTX): Chartists Are Taking Note - Stock Press Daily

When undertaking stock analysis, investors and traders may choose to view some additional technical levels. Akari Therapeutics PLC (AKTX) currently has a 14-day Commodity Channel Index (CCI) of -49.95. Investors and traders may use this indicator to ...altro » Leggi

Analysts See $-0.70 EPS for Akari Therapeutics PLC (ADR) (AKTX), Selkirk Management Trimmed Priceline.Com Cmn ... - Herald KS

After having $-0.09 EPS previously, Akari Therapeutics PLC (ADR)'s analysts see 677.78% EPS growth. About 49,798 shares traded. Akari Therapeutics PLC (ADR) (NASDAQ:AKTX) has declined 48.07% since July 25, 2016 and is downtrending.altro » Leggi

Akari Therapeutics PLC (AKTX) Getting Somewhat Favorable Media ... - Community Financial News

News headlines about Akari Therapeutics PLC (NASDAQ:AKTX) have trended somewhat positive recently, Accern Sentiment reports. The research firm ... Leggi

Akari Therapeutics PLC (AKTX) Given “Buy” Rating at Canaccord Genuity - Sports Perspectives

Shares of Akari Therapeutics PLC (AKTX) traded down 1.08% during midday trading on Monday, reaching $4.58. 49,936 shares of the company's stock were exchanged. The company's market cap is $53.93 million. Akari Therapeutics PLC has a 12-month ... Leggi

Hot Stocks Among Investors: Akari Therapeutics, Plc (AKTX), Eleven Biotherapeutics, Inc. (EBIO) - Post Analyst

... trading at a distance of 7.65% and stays -18.43% away from its 50 days moving average. Over the last five days, shares have managed 12.53% gains and now is down -38.33% since hitting its 200-day moving average of $8.38. Akari Therapeutics, Plc ...altro » Leggi

Orbital ATK (OA) Investors: Jefferies Keeps Buy Rating, Sees $115.0000/Share, Akari Therapeutics Plc Adr (AKTX ... - FlintDaily.com

The SI to Akari Therapeutics Plc Adr's float is 0.56%. The stock decreased 1.28% or $0.06 on July 21, reaching $4.63. About shares traded. Akari Therapeutics PLC (ADR) (NASDAQ:AKTX) has declined 48.07% since July 24, 2016 and is downtrending.altro » Leggi

Akari Therapeutics PLC (AKTX) Given News Impact Score of 0.16 ... - Transcript Daily

Media headlines about Akari Therapeutics PLC (NASDAQ:AKTX) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. Leggi

Amarin Corporation plc (AMRN) registers a price change of -0.50% while Akari Therapeutics, Plc (AKTX) finishes with ... - Stocks Gallery

In recent trading day Amarin Corporation plc (AMRN) stock showed the move of -0.50% with the closing price of $4.00. Closing price generally refers to the last price at which a stock trades during a regular trading session. The company moved in the ...altro » Leggi

Zacks Investment Research Downgrades Akari Therapeutics PLC ... - Sports Perspectives

Zacks Investment Research cut shares of Akari Therapeutics PLC (NASDAQ:AKTX) from a hold rating to a sell rating in a report published on Friday, June 30th.altro » Leggi